UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low-Dose Oral Naloxone Reverses Opioid-Induced Constipation and Analgesia

Journal of pain and symptom management, 2002, Vol.23 (1), p.48-53

2002

Volltextzugriff (PDF)

AB1168 Polychronic Disease Burden in Patients with Gout and Moderate to Severe Chronic Kidney Disease Receiving Urate-Lowering Therapies

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.1293-1293

2015

Volltextzugriff (PDF)

Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD

International journal of chronic obstructive pulmonary disease, 2019-01, Vol.14, p.1377-1388

2019

Volltextzugriff (PDF)

POS-300 Patient-reported early stage chronic kidney disease

Kidney international reports, 2021-04, Vol.6 (4), p.S129-S129

2021

Volltextzugriff (PDF)

POS-328 THE BURDEN OF HYPERKALEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT

Kidney international reports, 2021-04, Vol.6 (4), p.S141-S142

2021

Volltextzugriff (PDF)

POS-329 TREATMENT PATTERNS IN CHRONIC KIDNEY DISEASE PATIENTS WITH HYPERKALEMIA: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT

Kidney international reports, 2021-04, Vol.6 (4), p.S142-S143

2021

Volltextzugriff (PDF)

POS-318 PATIENT PREFERENCES FOR RISKS AND BENEFITS OF MEDICATIONS TO MANAGE ANEMIA OF CHRONIC KIDNEY DISEASE: A DISCRETE CHOICE EXPERIMENT

Kidney international reports, 2021-04, Vol.6 (4), p.S136-S137

2021

Volltextzugriff (PDF)

POS-526 UNDERSTANDING THE PATIENT EXPERIENCE AND CLINICAL COURSE DURING THE INCIDENT DIALYSIS PERIOD: DESIGN AND IMPLEMENTATION OF A DOPPS CHINA STUDY

Kidney international reports, 2021-04, Vol.6 (4), p.S229-S229

2021

Volltextzugriff (PDF)

POS-264 PATIENT PALATABILITY AND PREFERENCE STUDY OF 3 POTASSIUM BINDERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERKALAEMIA: RATIONALE AND DESIGN OF THE APPETIZE STUDY

Kidney international reports, 2021-04, Vol.6 (4), p.S112-S112

2021

Volltextzugriff (PDF)

Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult

Critical care medicine, 2002-01, Vol.30 (1), p.119-141

2002

Volltextzugriff (PDF)

Contemporary description of cardiac manifestations in ATTR amyloidosis: results from the multi-country OverTTuRe study

European heart journal, 2024-10, Vol.45 (Supplement_1)

2024

Volltextzugriff (PDF)

SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL

Journal of the American College of Cardiology, 2018-06, Vol.71 (22), p.2497-2506

2018

Volltextzugriff (PDF)

Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers

International journal of chronic obstructive pulmonary disease, 2019-01, Vol.14, p.101-114

2019

Volltextzugriff (PDF)

Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study

The lancet. Diabetes & endocrinology, 2020-07, Vol.8 (7), p.606-615

2020

Volltextzugriff (PDF)

Prevalence of and factors associated with undiagnosed stage 3 chronic kidney disease in patient with a history of heart failure: a report from REVEAL-CKD

European heart journal, 2021-10, Vol.42 (Supplement_1)

2021

Volltextzugriff (PDF)

PSY125 - Comparison of Low-Dose Liraglutide Use Versus other GLP-1 Receptor Agonists In Patients Without Type 2 Diabetes

Value in health, 2017-10, Vol.20 (9), p.A566-A566

2017

Volltextzugriff (PDF)

Comparison of Low-Dose Liraglutide Use Versus other GLP-1 Receptor Agonists In Patients Without Type 2 Diabetes

Value in health, 2017-10, Vol.20 (9), p.A566

2017

Volltextzugriff (PDF)

Association of sodium‐glucose cotransporter‐2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD‐REAL 2 study

Diabetes, obesity & metabolism, 2021-06, Vol.23 (6), p.1431-1435

2021

Volltextzugriff (PDF)

Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapy

Supportive care in cancer, 2019-02, Vol.27 (2), p.687-696

2019

Volltextzugriff (PDF)

PUK6 COST AND HEALTHCARE RESOURCE USE IN PATIENTS WITH ANEMIA IN CKD USING LINKED US CLAIMS AND ELECTRONIC HEALTH RECORDS

Value in health, 2020-05, Vol.23, p.S378-S378

2020

Volltextzugriff (PDF)

Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort

Advances in therapy, 2024-08, Vol.41 (8), p.3264-3277

2024

Volltextzugriff (PDF)

The ideal sedation assessment tool: An elusive instrument

Critical care medicine, 1999-07, Vol.27 (7), p.1384-1385

Wittbrodt, Eric T

1999

Volltextzugriff (PDF)

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study

Diabetes, obesity & metabolism, 2018-08, Vol.20 (8), p.1983-1987

2018

Volltextzugriff (PDF)

Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research

Diabetes, metabolic syndrome and obesity, 2017, Vol.10, p.123-139

2017

Volltextzugriff (PDF)

Methods and rationale of the DISCOVER CKD global observational study

Clinical Kidney Journal, 2021-06, Vol.14 (6), p.1570-1578

2021

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(87)

Publikationsform

Sprache

Englisch
(98)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Low-Dose Oral Naloxone Reverses Opioid-Induced Constipation and Analgesia

AB1168 Polychronic Disease Burden in Patients with Gout and Moderate to Severe Chronic Kidney Disease Receiving Urate-Lowering Therapies

Patient-reported outcomes of dual bronchodilator fixed-dose combination versus bronchodilator monotherapy in individuals with COPD

POS-300 Patient-reported early stage chronic kidney disease

POS-328 THE BURDEN OF HYPERKALEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT

POS-329 TREATMENT PATTERNS IN CHRONIC KIDNEY DISEASE PATIENTS WITH HYPERKALEMIA: A REPORT FROM THE DISCOVER CKD RETROSPECTIVE COHORT

POS-318 PATIENT PREFERENCES FOR RISKS AND BENEFITS OF MEDICATIONS TO MANAGE ANEMIA OF CHRONIC KIDNEY DISEASE: A DISCRETE CHOICE EXPERIMENT

POS-526 UNDERSTANDING THE PATIENT EXPERIENCE AND CLINICAL COURSE DURING THE INCIDENT DIALYSIS PERIOD: DESIGN AND IMPLEMENTATION OF A DOPPS CHINA STUDY

POS-264 PATIENT PALATABILITY AND PREFERENCE STUDY OF 3 POTASSIUM BINDERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERKALAEMIA: RATIONALE AND DESIGN OF THE APPETIZE STUDY

Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult

Contemporary description of cardiac manifestations in ATTR amyloidosis: results from the multi-country OverTTuRe study

SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL

Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers

Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study

Prevalence of and factors associated with undiagnosed stage 3 chronic kidney disease in patient with a history of heart failure: a report from REVEAL-CKD

PSY125 - Comparison of Low-Dose Liraglutide Use Versus other GLP-1 Receptor Agonists In Patients Without Type 2 Diabetes

Comparison of Low-Dose Liraglutide Use Versus other GLP-1 Receptor Agonists In Patients Without Type 2 Diabetes

Association of sodium‐glucose cotransporter‐2 inhibitors with outcomes in type 2 diabetes with reduced and preserved left ventricular ejection fraction: Analysis from the CVD‐REAL 2 study

Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapy

PUK6 COST AND HEALTHCARE RESOURCE USE IN PATIENTS WITH ANEMIA IN CKD USING LINKED US CLAIMS AND ELECTRONIC HEALTH RECORDS

Clinical Outcomes in Patients with CKD and Rapid or Non-rapid eGFR Decline: A Report from the DISCOVER CKD Retrospective Cohort

The ideal sedation assessment tool: An elusive instrument

Rates of myocardial infarction and stroke in patients initiating treatment with SGLT2‐inhibitors versus other glucose‐lowering agents in real‐world clinical practice: Results from the CVD‐REAL study

Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research

Methods and rationale of the DISCOVER CKD global observational study

Suchergebnisse filtern